MYCT1
Myc target protein 1
Also known as: FLJ21269, MTLC, MYCT1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N699
- Gene
- MYCT1
- Ensembl
- ENSG00000120279
- Chromosome
- 6
- Canonical length
- 235 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies,Vesicles
OverviewNCBI Gene
Predicted to act upstream of or within hematopoietic stem cell homeostasis. Located in nuclear body. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
235 residues, UniProt reviewed canonical sequence.
>Q8N699|MYCT1
1 MRTQVYEGLC KNYFSLAVLQ RDRIKLLFFD ILVFLSVFLL FLLFLVDIMA NNTTSLGSPW
61 PENFWEDLIM SFTVSMAIGL VLGGFIWAVF ICLSRRRRAS APISQWSSSR RSRSSYTHGL
121 NRTGFYRHSG CERRSNLSLA SLTFQRQASL EQANSFPRKS SFRASTFHPF LQCPPLPVET
181 ESQLVTLPSS NISPTISTSH SLSRPDYWSS NSLRVGLSTP PPPAYESIIK AFPDSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MYCT1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.62
- Highest tissue expression
- 47 nTPM
Expression across tissuesHPA
Tissue
- spleen: 47 nTPM
- adipose tissue: 26 nTPM
- breast: 21 nTPM
- placenta: 20 nTPM
- tongue: 19 nTPM
- heart muscle: 17 nTPM
Single-cell type
- hematopoietic stem cells: 163 nCPM
- vascular endothelial cells: 149 nCPM
- lymphatic endothelial cells: 141 nCPM
- megakaryocyte-erythroid progenitors: 131 nCPM
- platelets: 109 nCPM
- megakaryocyte progenitors: 69 nCPM
Immune cell
- eosinophil: 31 nTPM
- basophil: 0.9 nTPM
- neutrophil: 0.6 nTPM
- total PBMC: 0.6 nTPM
- naive B-cell: 0.1 nTPM
- NK-cell: 0.1 nTPM
Brain region
- cerebral cortex: 15 nTPM
- thalamus: 14 nTPM
- pons: 11 nTPM
- medulla oblongata: 8.9 nTPM
- white matter: 8.3 nTPM
- hypothalamus: 7.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.45
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.13
- DepMap mean gene effect
- 0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Myc target protein 1
- Myc target protein 1
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MYCT1 as an antibody target. Whether an autoantibody or antibody against MYCT1 could matter depends on whether native MYCT1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MYCT1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MYCT1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...